Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Levothyroxine sodium 125micrograms/5ml oral suspension |
| BNF code | 0602010V0AACYCY |
| Virtual Therapeutic Moiety | Levothyroxine |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Date of name applicability | 1 Dec 2004 |
| Previous name | Levothyroxine sodium 125micrograms/5ml oral suspension |
| Basis of previous name | INNM - International Non-proprietary Name (Modified) |
| Reason for name change | Other |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Continuous |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Levothyroxine sodium anhydrous |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 25.000 |
| Strength value numerator unit | microgram |
| Strength value denominator | 1.000 |
| Strength value denominator unit | ml |
| Ontology Drug Form & Route | |
| Form & Route | suspension.oral |
| Dose Form | |
| Formulation | Oral suspension |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Levothyroxine sodium 125micrograms/5ml oral suspension (Special Order) | |
| Virtual Medicinal Product Packs | |
| Levothyroxine sodium 125micrograms/5ml oral suspension 1 ml | |
dm+d data retrieved from TRUD: release NHSBSA_11.3.0_20241125000001, imported on 26th November 2024 at 03:54:16.